Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Revenue
Tandem Diabetes Care Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Revenue
$940.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
34%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$16.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Tandem Diabetes Care Inc
Revenue Breakdown
Breakdown by Geography
Tandem Diabetes Care Inc
|
Total Revenue:
940.2m
USD
|
|
United States:
672.7m
USD
|
|
Outside The United States:
267.5m
USD
|
Breakdown by Segments
Tandem Diabetes Care Inc
|
Total Revenue:
940.2m
USD
|
|
Supplies And Other:
475.8m
USD
|
|
Pump:
434.2m
USD
|
|
Net Revenue Recognized (Deferred) For Tandem ...:
30.2m
USD
|
Tandem Diabetes Care Inc
Glance View
Tandem Diabetes Care Inc., a prominent figure in the healthcare sector, has carved out a notable niche with its innovative diabetes management solutions. Founded in 2006 and headquartered in San Diego, California, the company has become a leader in providing advanced insulin pump technologies. Central to Tandem’s business model is their flagship product, the t:slim X2 Insulin Pump, a sleek and user-friendly device praised for its ease of use and functionality. Through meticulous engineering and design, Tandem has positioned itself at the forefront of modern diabetes management by enhancing user experience and integrating advanced technologies such as continuous glucose monitoring (CGM) compatibility, making diabetes care more dynamic and responsive. Revenue for Tandem Diabetes Care primarily flows from the sale of these insulin pumps, along with associated supplies and accessories, which are crucial for ongoing diabetes management. The company also generates income through software and technology upgrades. By offering a subscription-based model, Tandem ensures steady revenue from the continual acquisition of consumables and technology updates, fostering customer loyalty and long-term engagement. Their commitment to innovation and patient-centric solutions has not only allowed them to tap into a growing market of diabetes patients seeking improved quality of life but has also strengthened their competitive edge in a rapidly evolving healthcare landscape.
See Also
What is Tandem Diabetes Care Inc's Revenue?
Revenue
940.2m
USD
Based on the financial report for Dec 31, 2024, Tandem Diabetes Care Inc's Revenue amounts to 940.2m USD.
What is Tandem Diabetes Care Inc's Revenue growth rate?
Revenue CAGR 10Y
34%
Over the last year, the Revenue growth was 26%. The average annual Revenue growth rates for Tandem Diabetes Care Inc have been 10% over the past three years , 21% over the past five years , and 34% over the past ten years .
You don't have any saved screeners yet